SCHEMBL24815801

SCHEMBL24815801

O=C(CCS(=O)(=O)c1ccccc1Cl)N1Cc2ccccc2C1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.48
▸ TDP1 Q9NUW8 1/20 0.47
▸ MAPT P10636 2/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ TAS1R3 Q7RTX0 1/20 0.43
▸ TAS1R1 Q7RTX1 1/20 0.43
▸ TAS1R2 Q8TE23 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ POLB P06746 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ NOTUM Q6P988 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ LMNA P02545 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ THRB P10828 1/20 0.41
▸ SPR P35270 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29987207 1.00 ALDH1A1 (0.48) ALDH1A1TDP1MAPTKMT2ATAS1R3
SCHEMBL24814458 0.86 TAS1R3 (0.46) ALDH1A1MAPTTAS1R3TAS1R1TAS1R2
SCHEMBL29986800 0.86 TAS1R3 (0.46) ALDH1A1MAPTTAS1R3TAS1R1TAS1R2
SCHEMBL29987602 0.80 RAB9A (0.65) ALDH1A1KMT2AGAARAB9APOLB
SCHEMBL24814720 0.80 RAB9A (0.65) ALDH1A1KMT2AGAARAB9APOLB
SCHEMBL24814431 0.77 TAS1R3 (0.43) ALDH1A1TDP1MAPTKMT2ATAS1R3
SCHEMBL29986760 0.77 TAS1R3 (0.43) ALDH1A1TDP1MAPTKMT2ATAS1R3
SCHEMBL29367172 0.73 HDAC3 (0.63) ALDH1A1MAPTKMT2ASMN1; SMN2NOTUM
SCHEMBL24817140 0.72 NOTUM (0.52) ALDH1A1MAPTKMT2ATAS1R3TAS1R1
SCHEMBL29987139 0.72 NOTUM (0.52) ALDH1A1MAPTKMT2ATAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH ALDH1A1 3533/4885TDP1 3404/4885MAPT 4407/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH ALDH1A1 3533/4885TDP1 3404/4885MAPT 4407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback